SlideShare a Scribd company logo
PRESENTED BY:
APOORVA MISHRA
M.PHARM (PHARMACOLOGY)
Ist Semester
GUIDED BY:
DR. SAUMYA DA
ASSOCIATE PROFESSOR
NIET (PHARMACY INSTITUTE)
INTERNATIONAL COUNCIL FOR HARMONIZATION
 ICH stands for "International Conference on
Harmonization of Technical Requirements for
Registration of Pharmaceuticals for Human Use".
 ICH is a joint initiative of the regulatory authorities and
pharmaceutical industries of European Union, Japan
and the USA for the scientific and technical discussions
of the testing procedures required to assess and ensure
the safety, quality and efficacy of medicines.
 To increase safety, efficacy and quality of medicine
 To harmonize technical requirement for registration or
marketing approval.
 To develop & register pharmaceutical in efficient &
cost effective manner.
 To prevent unnecessary duplication of clinical trial on
human.
 To minimize use of animal testing without
compromising safety & efficacy of drugs.
 Promote public health by early availability of drug in the
market.
 Maintaining safeguards on quality, safety and efficacy.
 Improve efficiency of new drug development Reduce
registration cost.
 Less expensive drugs for patients.
 Prevent the duplication of clinical trails in humans.
 Minimize the animal use with out compromising in safety
efficacy of the product.
 Mutual acceptance of clinical data by regulatory authority.
 Reducing testing duplication.
 To promote international harmonization.
 To discuss and establish common guidelines.
 To provide information on ICH activities to other
countries.
 To promote understanding of initiative and facilitate
harmonization globally.
 To strengthen capacity of drug regulatory authorities
and industry to utilize them.
 Harmonization of regulatory requirements was pioneered
by the EU, Europe, in the 1980s as the Europe move
towards the development of single market.
 The success achieved in Europe demonstrated that
harmonization was feasibile. At the same time there were
discussions between Europe, Japan and the US on
possibilities for harmonization. The birth of ICH took place
at a meeting in April 1990. Topics selected for
harmonisation would be divided into safety, quality and
efficacy to reflect the three criteria which are the basis for
approving and authorising new medicinal products.
 First decade : Significant progress in the development
of ICH Guidelines on Safety, Quality and Efficacy
topics and also work on a number of important
multidisciplinary topics.
 Second decade : Implementation of ICH Guidelines in
the ICH regions. Expand communication and
information on ICH Guidelines with other regions.
 Third decade : Extending the benefits of harmonisation
beyond the ICH regions. Training,as well as active
participation of other regions in Guideline development
is seen as key in this effort.
 EU
 EFPIA (European federation of pharmaceutical
industries' associations).
 MHLW (Ministry of health, Labor and welfare, Japan)
 JPMA (Japan Pharmaceuticals manufacturers
Association).
 US FDA
 PhRMA(pharmaceutical research and manufacturers
association)
REF:https://www.sciencedirect.com/science/article/pii/B978012822211900008
3
STEP 5-Implementing Guidelines in ICH Regions
STEP 4-Adopting Harmonized Guidelines
STEP 3-Consulting Regional Regulatory Agencies
STEP 2-Agreeing on Draft Text
STEP 1-Building Scientific Consensus
 Quality guidelines
 Safety guidelines
 Efficacy guidelines
 Multidisciplinary guidelines.
 QUALITY: Harmonization achievements in the Quality
area include such as the conduct of stability studies,
defining relevant thresholds for impurities testing and a
more flexible approach to pharmaceutical quality based
on Good Manufacturing Practice (GMP) risk
management.
 SAFETY: ICH has produced a comprehensive set of
safety Guidelines to potential risks like carcinogenicity,
genotoxicity and reprotoxicity etc.
 EFFICACY: The work carried out by ICH under the
Efficacy heading is concerned with the design, conduct,
safety and reporting of clinical trials. It also covers novel
types of medicines derived from biotechnological processes
and the use of pharmacogenetics/ genomics techniques to
produce better targeted medicines.
 MULTIDISCPLINARY: These are the cross-cutting topics
which do not fit uniquely into one of the Quality, Safety and
Efficacy categories. It includes the ICH medical
terminology (MedDRA), the Common Technical Document
(CTD) and the development of Electronic Standards for the
Transfer of Regulatory Information (ESTRI).
QIA-QIF: Stability
Q2: Analytical Validation
Q3A-Q3D: Impurities
Q4-Q4B: Pharmacopoeias
Q5A-Q5E: Quality of Biotechnological Products
Q6A-Q6B: Specifications
Q7: Good Manufacturing Practice
Q8: Pharmaceutical Development
Q9: Quality Risk Management
Q10: Pharmaceutical Quality System
Q11: Development and Manufacture of Drug Substances
Q12: Lifecycle Management
Q13: Continuous Manufacturing of Drug Substances and Drug Products
Q14: Analytical Procedure Development
SIA-SIC: Carcinogenicity Studies
S2: Genotoxicity Studies
S3A-S3B: Toxicokinetics and Pharmacokinetics
S4: Toxicity Testing
S5: Reproductive Toxicology
S6: Biotechnological Products
S7A-S7B: Pharmacology Studies
S8: Immunotoxicology Studies
S9: Nonclinical Evaluation for Anticancer Pharmaceuticals
S10: Photosafety Evaluation
S11 : Nonclinical Pediatric Safety
E1: Clinical Safety for Drugs used in Long-Term Treatment
E2A - E2F : Pharmacovigilance
E3: Clinical Study Reports
E4: Dose-Response Studies
E5: Ethnic Factors
E6: Good Clinical Practice
E7 :Clinical Trials in Geriatric Population
E8: General Considerations for Clinical Trials
E9 Statistical Principles for Clinical Trials
E10: Choice of Control Group in Clinical Trials
E11: Clinical Trials in Pediatric Population
E12 Clinical Evaluation by Therapeutic Category
E14 Clinical Evaluation of QT
E15 Definitions in Pharmacogenetics / Pharmacogenomics
E17: Multi-Regional Clinical Trials
E18: Genomic Sampling
M1: MedDRA Terminology
M2: Electronic Standards
M3: Nonclinical Safety Studies
M4: Common Technical Document
M5: Data Elements and Standards for Drug Dictionaries
M6: Gene Therapy
M7: Mutagenic impurities
M8: Electronic Common Technical Document (eCTD)
M9: Biopharmaceutics Classification System-based
Biowaivers
M10: Bioanalytical Method Validation
https://www.slideshare.net/bharathpharmacist/ich-
guidelines-39685947
https://www.slideshare.net/jayaprakash373/ich-and-ich-
guidelines
https://www.ich.org/
https://www.pharmaguideline.com/2010/10/ich.html?m=
1
https://www.fda.gov/science-research/clinical-trials-and-
human-subject-protection/ich-guidance-documents
THANK YOU

More Related Content

Similar to ICH PPT

ICH GUIDELINES OF ICH–QSEM detailed.pptx
ICH GUIDELINES OF ICH–QSEM detailed.pptxICH GUIDELINES OF ICH–QSEM detailed.pptx
ICH GUIDELINES OF ICH–QSEM detailed.pptx
Nishanth Arunodayam
 
ich ppt ok tested.pptxaaaaàaaaaaaaaaaaaa
ich ppt ok tested.pptxaaaaàaaaaaaaaaaaaaich ppt ok tested.pptxaaaaàaaaaaaaaaaaaa
ich ppt ok tested.pptxaaaaàaaaaaaaaaaaaa
SiddeshKokate
 
Ich guidelines with all process ,members, objectives
Ich guidelines with all process ,members, objectivesIch guidelines with all process ,members, objectives
Ich guidelines with all process ,members, objectives
miteshlungase008
 
ICH GUIDELINES AND ITS IMPACT IN INDIA
ICH GUIDELINES AND ITS IMPACT IN INDIAICH GUIDELINES AND ITS IMPACT IN INDIA
ICH GUIDELINES AND ITS IMPACT IN INDIA
asmitadey785
 
Regulatory Standard - ICH-Pharmacy regulatory affairs.ppt
Regulatory Standard - ICH-Pharmacy regulatory affairs.pptRegulatory Standard - ICH-Pharmacy regulatory affairs.ppt
Regulatory Standard - ICH-Pharmacy regulatory affairs.ppt
ArafatSaad1
 
Ich guidelines seminar
Ich guidelines seminarIch guidelines seminar
Ich guidelines seminarMd Gayasuddin
 
Ich guideline
Ich guidelineIch guideline
Ich guideline
aishwaryaPatil86
 
ICH_Public_Mtg._Montreal_2017-converted.pptx
ICH_Public_Mtg._Montreal_2017-converted.pptxICH_Public_Mtg._Montreal_2017-converted.pptx
ICH_Public_Mtg._Montreal_2017-converted.pptx
RamchandraKeny
 
Ich guidelines ppt
Ich guidelines pptIch guidelines ppt
PROCESS OF ICH (International Council for Harmonisation)
PROCESS OF ICH (International Council for Harmonisation)PROCESS OF ICH (International Council for Harmonisation)
PROCESS OF ICH (International Council for Harmonisation)
Swathi P
 
Ich quality guidelines
Ich quality guidelinesIch quality guidelines
Ich quality guidelines
SAMEERS17
 
ICH guideline.pdf
ICH guideline.pdfICH guideline.pdf
ICH guideline.pdf
Zeelshah2258
 
International council for harmonization by akshay trivedi
International council for harmonization by akshay trivediInternational council for harmonization by akshay trivedi
International council for harmonization by akshay trivedi
Akshay Trivedi , Maliba Pharmacy College
 
ICH GUIDELINES FOR TESTING OF HERBAL DRUGS AYANSH SINGH.pptx
ICH GUIDELINES FOR TESTING OF HERBAL DRUGS AYANSH SINGH.pptxICH GUIDELINES FOR TESTING OF HERBAL DRUGS AYANSH SINGH.pptx
ICH GUIDELINES FOR TESTING OF HERBAL DRUGS AYANSH SINGH.pptx
AyanshSingh11
 
ICH Guideline For Herbal Drugs.pptx
ICH Guideline For Herbal Drugs.pptxICH Guideline For Herbal Drugs.pptx
ICH Guideline For Herbal Drugs.pptx
Easy Concept
 
ICH
ICHICH
ICH
ICHICH

Similar to ICH PPT (20)

ICH GUIDELINES OF ICH–QSEM detailed.pptx
ICH GUIDELINES OF ICH–QSEM detailed.pptxICH GUIDELINES OF ICH–QSEM detailed.pptx
ICH GUIDELINES OF ICH–QSEM detailed.pptx
 
ICH
ICHICH
ICH
 
ich ppt ok tested.pptxaaaaàaaaaaaaaaaaaa
ich ppt ok tested.pptxaaaaàaaaaaaaaaaaaaich ppt ok tested.pptxaaaaàaaaaaaaaaaaaa
ich ppt ok tested.pptxaaaaàaaaaaaaaaaaaa
 
Ich
IchIch
Ich
 
Ich guidelines with all process ,members, objectives
Ich guidelines with all process ,members, objectivesIch guidelines with all process ,members, objectives
Ich guidelines with all process ,members, objectives
 
Ich
IchIch
Ich
 
ICH GUIDELINES AND ITS IMPACT IN INDIA
ICH GUIDELINES AND ITS IMPACT IN INDIAICH GUIDELINES AND ITS IMPACT IN INDIA
ICH GUIDELINES AND ITS IMPACT IN INDIA
 
Regulatory Standard - ICH-Pharmacy regulatory affairs.ppt
Regulatory Standard - ICH-Pharmacy regulatory affairs.pptRegulatory Standard - ICH-Pharmacy regulatory affairs.ppt
Regulatory Standard - ICH-Pharmacy regulatory affairs.ppt
 
Ich guidelines seminar
Ich guidelines seminarIch guidelines seminar
Ich guidelines seminar
 
Ich guideline
Ich guidelineIch guideline
Ich guideline
 
ICH_Public_Mtg._Montreal_2017-converted.pptx
ICH_Public_Mtg._Montreal_2017-converted.pptxICH_Public_Mtg._Montreal_2017-converted.pptx
ICH_Public_Mtg._Montreal_2017-converted.pptx
 
Ich guidelines ppt
Ich guidelines pptIch guidelines ppt
Ich guidelines ppt
 
PROCESS OF ICH (International Council for Harmonisation)
PROCESS OF ICH (International Council for Harmonisation)PROCESS OF ICH (International Council for Harmonisation)
PROCESS OF ICH (International Council for Harmonisation)
 
Ich quality guidelines
Ich quality guidelinesIch quality guidelines
Ich quality guidelines
 
ICH guideline.pdf
ICH guideline.pdfICH guideline.pdf
ICH guideline.pdf
 
International council for harmonization by akshay trivedi
International council for harmonization by akshay trivediInternational council for harmonization by akshay trivedi
International council for harmonization by akshay trivedi
 
ICH GUIDELINES FOR TESTING OF HERBAL DRUGS AYANSH SINGH.pptx
ICH GUIDELINES FOR TESTING OF HERBAL DRUGS AYANSH SINGH.pptxICH GUIDELINES FOR TESTING OF HERBAL DRUGS AYANSH SINGH.pptx
ICH GUIDELINES FOR TESTING OF HERBAL DRUGS AYANSH SINGH.pptx
 
ICH Guideline For Herbal Drugs.pptx
ICH Guideline For Herbal Drugs.pptxICH Guideline For Herbal Drugs.pptx
ICH Guideline For Herbal Drugs.pptx
 
ICH
ICHICH
ICH
 
ICH
ICHICH
ICH
 

Recently uploaded

Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
Celine George
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
Steve Thomason
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
Vivekanand Anglo Vedic Academy
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
Basic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumersBasic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumers
PedroFerreira53928
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
Col Mukteshwar Prasad
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdfESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
Fundacja Rozwoju Społeczeństwa Przedsiębiorczego
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 

Recently uploaded (20)

Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
Basic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumersBasic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumers
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdfESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 

ICH PPT

  • 1. PRESENTED BY: APOORVA MISHRA M.PHARM (PHARMACOLOGY) Ist Semester GUIDED BY: DR. SAUMYA DA ASSOCIATE PROFESSOR NIET (PHARMACY INSTITUTE) INTERNATIONAL COUNCIL FOR HARMONIZATION
  • 2.  ICH stands for "International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use".  ICH is a joint initiative of the regulatory authorities and pharmaceutical industries of European Union, Japan and the USA for the scientific and technical discussions of the testing procedures required to assess and ensure the safety, quality and efficacy of medicines.
  • 3.  To increase safety, efficacy and quality of medicine  To harmonize technical requirement for registration or marketing approval.  To develop & register pharmaceutical in efficient & cost effective manner.  To prevent unnecessary duplication of clinical trial on human.  To minimize use of animal testing without compromising safety & efficacy of drugs.
  • 4.  Promote public health by early availability of drug in the market.  Maintaining safeguards on quality, safety and efficacy.  Improve efficiency of new drug development Reduce registration cost.  Less expensive drugs for patients.  Prevent the duplication of clinical trails in humans.  Minimize the animal use with out compromising in safety efficacy of the product.  Mutual acceptance of clinical data by regulatory authority.  Reducing testing duplication.
  • 5.  To promote international harmonization.  To discuss and establish common guidelines.  To provide information on ICH activities to other countries.  To promote understanding of initiative and facilitate harmonization globally.  To strengthen capacity of drug regulatory authorities and industry to utilize them.
  • 6.  Harmonization of regulatory requirements was pioneered by the EU, Europe, in the 1980s as the Europe move towards the development of single market.  The success achieved in Europe demonstrated that harmonization was feasibile. At the same time there were discussions between Europe, Japan and the US on possibilities for harmonization. The birth of ICH took place at a meeting in April 1990. Topics selected for harmonisation would be divided into safety, quality and efficacy to reflect the three criteria which are the basis for approving and authorising new medicinal products.
  • 7.  First decade : Significant progress in the development of ICH Guidelines on Safety, Quality and Efficacy topics and also work on a number of important multidisciplinary topics.  Second decade : Implementation of ICH Guidelines in the ICH regions. Expand communication and information on ICH Guidelines with other regions.  Third decade : Extending the benefits of harmonisation beyond the ICH regions. Training,as well as active participation of other regions in Guideline development is seen as key in this effort.
  • 8.  EU  EFPIA (European federation of pharmaceutical industries' associations).  MHLW (Ministry of health, Labor and welfare, Japan)  JPMA (Japan Pharmaceuticals manufacturers Association).  US FDA  PhRMA(pharmaceutical research and manufacturers association)
  • 10. STEP 5-Implementing Guidelines in ICH Regions STEP 4-Adopting Harmonized Guidelines STEP 3-Consulting Regional Regulatory Agencies STEP 2-Agreeing on Draft Text STEP 1-Building Scientific Consensus
  • 11.  Quality guidelines  Safety guidelines  Efficacy guidelines  Multidisciplinary guidelines.
  • 12.  QUALITY: Harmonization achievements in the Quality area include such as the conduct of stability studies, defining relevant thresholds for impurities testing and a more flexible approach to pharmaceutical quality based on Good Manufacturing Practice (GMP) risk management.  SAFETY: ICH has produced a comprehensive set of safety Guidelines to potential risks like carcinogenicity, genotoxicity and reprotoxicity etc.
  • 13.  EFFICACY: The work carried out by ICH under the Efficacy heading is concerned with the design, conduct, safety and reporting of clinical trials. It also covers novel types of medicines derived from biotechnological processes and the use of pharmacogenetics/ genomics techniques to produce better targeted medicines.  MULTIDISCPLINARY: These are the cross-cutting topics which do not fit uniquely into one of the Quality, Safety and Efficacy categories. It includes the ICH medical terminology (MedDRA), the Common Technical Document (CTD) and the development of Electronic Standards for the Transfer of Regulatory Information (ESTRI).
  • 14. QIA-QIF: Stability Q2: Analytical Validation Q3A-Q3D: Impurities Q4-Q4B: Pharmacopoeias Q5A-Q5E: Quality of Biotechnological Products Q6A-Q6B: Specifications Q7: Good Manufacturing Practice Q8: Pharmaceutical Development Q9: Quality Risk Management Q10: Pharmaceutical Quality System Q11: Development and Manufacture of Drug Substances Q12: Lifecycle Management Q13: Continuous Manufacturing of Drug Substances and Drug Products Q14: Analytical Procedure Development
  • 15. SIA-SIC: Carcinogenicity Studies S2: Genotoxicity Studies S3A-S3B: Toxicokinetics and Pharmacokinetics S4: Toxicity Testing S5: Reproductive Toxicology S6: Biotechnological Products S7A-S7B: Pharmacology Studies S8: Immunotoxicology Studies S9: Nonclinical Evaluation for Anticancer Pharmaceuticals S10: Photosafety Evaluation S11 : Nonclinical Pediatric Safety
  • 16. E1: Clinical Safety for Drugs used in Long-Term Treatment E2A - E2F : Pharmacovigilance E3: Clinical Study Reports E4: Dose-Response Studies E5: Ethnic Factors E6: Good Clinical Practice E7 :Clinical Trials in Geriatric Population E8: General Considerations for Clinical Trials E9 Statistical Principles for Clinical Trials E10: Choice of Control Group in Clinical Trials E11: Clinical Trials in Pediatric Population E12 Clinical Evaluation by Therapeutic Category E14 Clinical Evaluation of QT E15 Definitions in Pharmacogenetics / Pharmacogenomics E17: Multi-Regional Clinical Trials E18: Genomic Sampling
  • 17. M1: MedDRA Terminology M2: Electronic Standards M3: Nonclinical Safety Studies M4: Common Technical Document M5: Data Elements and Standards for Drug Dictionaries M6: Gene Therapy M7: Mutagenic impurities M8: Electronic Common Technical Document (eCTD) M9: Biopharmaceutics Classification System-based Biowaivers M10: Bioanalytical Method Validation